# Study of Voncento® in Subjects With Von Willebrand Disease

> **NCT02552576** · PHASE4 · COMPLETED · sponsor: **CSL Behring** · enrollment: 26 (actual)

## Conditions studied

- Von Willebrand Disease

## Interventions

- **BIOLOGICAL:** Voncento

## Key facts

- **NCT ID:** NCT02552576
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-05
- **Primary completion:** 2018-02-15
- **Final completion:** 2018-02-15
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2018-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02552576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02552576, "Study of Voncento® in Subjects With Von Willebrand Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02552576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*